Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients

Background: The ESE-ENSAT guidelines on the management of adrenocortical carcinoma (ACC) suggest adjuvant mitotane for patients at high risk of recurrence following radical surgery. This indication has a limited evidence base, lacking results from randomized controlled trials. No suggestion for or a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Endocr Soc
Main Authors: Terzolo, Massimo, Fassnacht, Martin, Perotti, Paola, Libe, Rossella, Lacroix, André, Kastelan, Darko, Haak, Harm Reinout, Arlt, Wiebke, Loli, Paola, Decoudier, Bénédicte, Lasolle, Helene, Bancos, Irina, Quinkler, Marcus, Villares Fragoso, Maria Candida Barisson, Canu, Letizia, Puglisi, Soraya, Kroiss, Matthias, Dusek, Tina, Bourdeau, Isabelle, Baudin, Eric, Berchialla, Paola, Beuschlein, Felix, Bertherat, Jerome Yves, Berruti, Alfredo
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Adrenal
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265733/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.336
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados